down arrow

ANG Lifesciences

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE236W01016
  • NSEID:
  • BSEID: 540694
INR
29.34
-0.15 (-0.51%)
BSENSE

Apr 11, 12:46 PM

BSE+NSE Vol: 2.11 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

28.0829.50

52 Week

21.0362.75
Valuation
Technical
Day's Volume

CASH

2.11 k (-80.77%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

70.60%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of -35.75% and Operating profit at -144.55% over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 52.88 times
2

The company has declared Negative results for the last 11 consecutive quarters

3

Stock is technically in a Bearish range

4

Risky - Negative Operating Profits

5

44.88% of Promoter Shares are Pledged

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 38 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.14

stock-summary
Return on Equity

-18.26%

stock-summary
Price to Book

0.54

Revenue and Profits (1 Year):
Net Sales:
25 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-5 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-40.8%
0%
-40.8%
1 Year
-50.47%
0%
-50.47%
2 Years
-66.45%
0%
-66.45%
3 Years
-88.46%
0%
-88.46%
4 Years
-18.5%
1.60%
-16.9%
5 Years
109.57%
6.47%
116.04%

Latest dividend: 1 per share ex-dividend date: Nov-02-2021

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-35.75%
EBIT Growth (5y)
-144.55%
EBIT to Interest (avg)
2.20
Debt to EBITDA (avg)
21.72
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.34
Tax Ratio
11.89%
Dividend Payout Ratio
0
Pledged Shares
44.88%
Institutional Holding
0
ROCE (avg)
9.07%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
0.54
EV to EBIT
-21.43
EV to EBITDA
67.43
EV to Capital Employed
0.79
EV to Sales
1.05
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-3.48%
ROE (Latest)
-18.26%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

44.8775

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Rajesh Gupta (70.41%)

Highest Public shareholder

None

Individual Investors Holdings

25.92%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 33.32% vs -60.47% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 12.48% vs -233.15% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "24.73",
          "val2": "18.55",
          "chgp": "33.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.15",
          "val2": "-1.91",
          "chgp": "-12.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.00",
          "val2": "2.51",
          "chgp": "-20.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.19",
          "val2": "-5.93",
          "chgp": "12.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-8.69%",
          "val2": "-10.30%",
          "chgp": "1.61%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -42.83% vs -32.81% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -805.26% vs -109.31% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "51.29",
          "val2": "89.72",
          "chgp": "-42.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.58",
          "val2": "8.20",
          "chgp": "-92.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.27",
          "val2": "4.60",
          "chgp": "-7.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.16",
          "val2": "-0.57",
          "chgp": "-805.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1.13%",
          "val2": "9.14%",
          "chgp": "-8.01%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -29.79% vs -40.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -59.23% vs -249.77% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "76.02",
          "val2": "108.27",
          "chgp": "-29.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.57",
          "val2": "6.29",
          "chgp": "-124.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "6.27",
          "val2": "7.11",
          "chgp": "-11.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-10.35",
          "val2": "-6.50",
          "chgp": "-59.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2.07%",
          "val2": "5.81%",
          "chgp": "-7.88%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -33.55% vs -37.94% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -3,800.00% vs -100.64% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "146.11",
          "val2": "219.89",
          "chgp": "-33.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9.65",
          "val2": "14.13",
          "chgp": "-31.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "10.96",
          "val2": "11.88",
          "chgp": "-7.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.74",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-10.14",
          "val2": "-0.26",
          "chgp": "-3,800.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.60%",
          "val2": "6.43%",
          "chgp": "0.17%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
24.73
18.55
33.32%
Operating Profit (PBDIT) excl Other Income
-2.15
-1.91
-12.57%
Interest
2.00
2.51
-20.32%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-5.19
-5.93
12.48%
Operating Profit Margin (Excl OI)
-8.69%
-10.30%
1.61%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 33.32% vs -60.47% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 12.48% vs -233.15% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
51.29
89.72
-42.83%
Operating Profit (PBDIT) excl Other Income
0.58
8.20
-92.93%
Interest
4.27
4.60
-7.17%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-5.16
-0.57
-805.26%
Operating Profit Margin (Excl OI)
1.13%
9.14%
-8.01%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -42.83% vs -32.81% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -805.26% vs -109.31% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
76.02
108.27
-29.79%
Operating Profit (PBDIT) excl Other Income
-1.57
6.29
-124.96%
Interest
6.27
7.11
-11.81%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-10.35
-6.50
-59.23%
Operating Profit Margin (Excl OI)
-2.07%
5.81%
-7.88%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -29.79% vs -40.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -59.23% vs -249.77% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
146.11
219.89
-33.55%
Operating Profit (PBDIT) excl Other Income
9.65
14.13
-31.71%
Interest
10.96
11.88
-7.74%
Exceptional Items
-1.74
0.00
Consolidate Net Profit
-10.14
-0.26
-3,800.00%
Operating Profit Margin (Excl OI)
6.60%
6.43%
0.17%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -33.55% vs -37.94% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -3,800.00% vs -100.64% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About ANG Lifesciences India Ltd stock-summary
stock-summary
ANG Lifesciences India Ltd
Micro Cap
Pharmaceuticals & Drugs
ANG Lifesciences India Limited was originally incorporated as a Private Limited Company with the name "ANG Lifesciences India Private Limited" on June 14, 2006. On conversion into Public Limited Company, the name was changed to ANG Lifesciences India Limited on March 02, 2010. The Company further converted into Private Limited Company and the name of the Company was changed to "ANG Lifesciences India Private Limited" on September 22, 2010.
Company Coordinates stock-summary
Company Details
Darbara Complex SCO 113 I Flr, Dist. Shopping Centre B Block Amritsar Punjab : 143001
stock-summary
Tel: 91-0183-5070118/5070119
stock-summary
http://www.anglifesciences.com
stock-summary
cs@anglifesciences.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."